Inhibrx Biosciences (INBX) Other Non-Current Assets (2023 - 2025)
Historic Other Non-Current Assets for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $5.7 million.
- Inhibrx Biosciences' Other Non-Current Assets fell 1451.13% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year decrease of 1451.13%. This contributed to the annual value of $6.8 million for FY2024, which is 11589.76% up from last year.
- Latest data reveals that Inhibrx Biosciences reported Other Non-Current Assets of $5.7 million as of Q3 2025, which was down 1451.13% from $6.8 million recorded in Q2 2025.
- In the past 5 years, Inhibrx Biosciences' Other Non-Current Assets ranged from a high of $6.8 million in Q4 2024 and a low of $3.2 million during Q4 2023
- In the last 3 years, Inhibrx Biosciences' Other Non-Current Assets had a median value of $6.7 million in 2024 and averaged $6.1 million.
- In the last 5 years, Inhibrx Biosciences' Other Non-Current Assets skyrocketed by 11589.76% in 2024 and then crashed by 1451.13% in 2025.
- Quarter analysis of 3 years shows Inhibrx Biosciences' Other Non-Current Assets stood at $3.2 million in 2023, then surged by 115.9% to $6.8 million in 2024, then dropped by 16.0% to $5.7 million in 2025.
- Its Other Non-Current Assets stands at $5.7 million for Q3 2025, versus $6.8 million for Q2 2025 and $6.8 million for Q1 2025.